Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Axelsson

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Multiple Sclerosis and Related Disorders|June 23, 2020
Can multiple sclerosis be cured? A case of highly active relapsing multiple sclerosis treated with autologous hematopoietic stem-cell transplantation 13 years agoJan Lycke, Markus Axelsson
BMC Neurology|May 5, 2019
Leukoencephalopathia, demyelinating peripheral neuropathy and dural ectasia explained by a not formerly described de novo mutation in the SAMD9L gene, ends 27 years of investigations - a case reportSofia Thunström, Markus Axelsson
Acta Neurologica Scandinavica|July 19, 2021
Fatigue, insomnia and daytime sleepiness in multiple sclerosis versus narcolepsyKalle Johansson, Pontus Wasling, Markus Axelsson
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|November 18, 2025
The Effect of Gadolinium on Synthetic Magnetic Resonance Quantitative ImagingLenka Novakova, Igal Rosenstein, Markus Axelsson, et al.
Brain Communications|March 21, 2025
Higher plasma neurofilament-light chain concentration in drug-resistant epilepsySarah Akel, Markus Axelsson, Fredrik Asztely, et al.
Acta Neurologica Scandinavica|May 10, 2019
Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonismRadu Constantinescu, Lars Rosengren, Barbro Eriksson, et al.
Brain and Behavior|October 8, 2019
Neuronal antibodies in adult patients with new-onset seizures: A prospective studyJohan Zelano, Markus Axelsson, Radu Constantinescu, et al.
Journal of Neuroimmunology|October 16, 2013
The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosisMarkus Axelsson, Niklas Mattsson, Clas Malmeström, et al.
Multiple Sclerosis and Related Disorders|April 19, 2019
A SCA7 premutation may be a novel Mendelian modifier of MS course: A case reportChristina Sundal, Markus Axelsson, Leif Wiklund, et al.
Neuroepidemiology|November 11, 2022
Decreased Incidence of Guillain-Barré Syndrome during the COVID-19 Pandemic: A Retrospective Population-Based StudyBrynhildur Hafsteinsdóttir, Ellen Dalemo, Ólöf Elíasdóttir, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Multiple Sclerosis and Related Disorders|June 23, 2020
Can multiple sclerosis be cured? A case of highly active relapsing multiple sclerosis treated with autologous hematopoietic stem-cell transplantation 13 years agoJan Lycke, Markus Axelsson
BMC Neurology|May 5, 2019
Leukoencephalopathia, demyelinating peripheral neuropathy and dural ectasia explained by a not formerly described de novo mutation in the SAMD9L gene, ends 27 years of investigations - a case reportSofia Thunström, Markus Axelsson
Acta Neurologica Scandinavica|July 19, 2021
Fatigue, insomnia and daytime sleepiness in multiple sclerosis versus narcolepsyKalle Johansson, Pontus Wasling, Markus Axelsson
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|November 18, 2025
The Effect of Gadolinium on Synthetic Magnetic Resonance Quantitative ImagingLenka Novakova, Igal Rosenstein, Markus Axelsson, et al.
Brain Communications|March 21, 2025
Higher plasma neurofilament-light chain concentration in drug-resistant epilepsySarah Akel, Markus Axelsson, Fredrik Asztely, et al.
Acta Neurologica Scandinavica|May 10, 2019
Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonismRadu Constantinescu, Lars Rosengren, Barbro Eriksson, et al.
Brain and Behavior|October 8, 2019
Neuronal antibodies in adult patients with new-onset seizures: A prospective studyJohan Zelano, Markus Axelsson, Radu Constantinescu, et al.
Journal of Neuroimmunology|October 16, 2013
The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosisMarkus Axelsson, Niklas Mattsson, Clas Malmeström, et al.
Multiple Sclerosis and Related Disorders|April 19, 2019
A SCA7 premutation may be a novel Mendelian modifier of MS course: A case reportChristina Sundal, Markus Axelsson, Leif Wiklund, et al.
Neuroepidemiology|November 11, 2022
Decreased Incidence of Guillain-Barré Syndrome during the COVID-19 Pandemic: A Retrospective Population-Based StudyBrynhildur Hafsteinsdóttir, Ellen Dalemo, Ólöf Elíasdóttir, et al.
Pageof 9